The29E.2A3monoclonalantibodyreactswithhumanPD-L1(programmeddeathligand1)alsoknownasB7-H1orCD274.PD-L1isa40kDatypeItransmembraneproteinthatbelongstotheB7familyoftheIgsuperfamily.PD-L1isexpressedonTlymphocytes,Blymphocytes,NKcells,dendriticcells,aswellasIFNγstimulatedmonocytes,epithelialcellsandendothelialcells.PD-L1bindstoitsreceptor,PD-1,foundonCD4andCD8thymocytesaswellasactivatedTandBlymphocytesandmyeloidcells.EngagementofPD-L1withPD-1leadstoinhibitionofTCR-mediatedTcellproliferationandcytokineproduction.PD-L1isthoughttoplayanimportantroleintumorimmuneevasion.InducedPD-L1expressioniscommoninmanytumorsandresultsinincreasedresistanceoftumorcellstoCD8Tcellmediatedlysis.The29E.2A3antibodyhasbeenshowntoblockthebindingofPD-1-IgtoPD-L1.
| Isotype | MouseIgG2b |
| RecomendedIsotypeControl(s) | InVivoMAbmouseIgG2bisotypecontrol,unknownspecificity |
| RecommendedInVivoPureDilutionBuffer | InVivoPurepH7.0DilutionBuffer |
| Immunogen | FulllengthhumanPD-L1 |
| ReportedApplications |
|
| Endotoxin |
|
| Purity |
|
| Formulation |
|
| Sterility | 0.2μMfiltered |
| Production | Purifiedfromtissueculturesupernatantinananimalfreefacility |
| Purification | ProteinG |
| Storage | Undilutedat4°Cinthedark |
